Intelectin-2 is a broad-spectrum antimicrobial lectin.
Saved in:
| Title: | Intelectin-2 is a broad-spectrum antimicrobial lectin. |
|---|---|
| Authors: | Dugan AE; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA., Syangtan D; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA., Nonnecke EB; Department of Microbiology and Immunology, School of Medicine, University of California-Davis, Davis, CA, USA., Chorghade RS; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA., Peiffer AL; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA., Yao JJ; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA., Ille-Bunn J; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA., Sergio D; The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Pishchany G; The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Dhennezel C; The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Vlamakis H; The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Bae S; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA., Johnson S; Department of Biochemistry, University of Wisconsin-Madison, Madison, WI, USA., Ellis C; Department of Biochemistry, University of Wisconsin-Madison, Madison, WI, USA., Ghosh S; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA., Alty JW; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA., Barnes CE; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA., Krupkin M; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA., Cárcamo-Oyarce G; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA., Ribbeck K; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA., Xavier RJ; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Molecular Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Bevins CL; Department of Microbiology and Immunology, School of Medicine, University of California-Davis, Davis, CA, USA., Kiessling LL; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA. kiesslin@mit.edu.; The Broad Institute of MIT and Harvard, Cambridge, MA, USA. kiesslin@mit.edu.; Department of Biochemistry, University of Wisconsin-Madison, Madison, WI, USA. kiesslin@mit.edu.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA. kiesslin@mit.edu. |
| Source: | Nature communications [Nat Commun] 2026 Jan 13; Vol. 17 (1), pp. 231. Date of Electronic Publication: 2026 Jan 13. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2041-1723 |
|---|---|
| DOI: | 10.1038/s41467-025-67099-4 |
